Annual Total Long Term Liabilities
$30.14 M
+$700.00 K+2.38%
December 31, 2023
Summary
- As of February 8, 2025, ELEV annual total long term liabilities is $30.14 million, with the most recent change of +$700.00 thousand (+2.38%) on December 31, 2023.
- During the last 3 years, ELEV annual total long term liabilities has fallen by -$67.07 million (-69.00%).
- ELEV annual total long term liabilities is now -69.00% below its all-time high of $97.20 million, reached on December 31, 2020.
Performance
ELEV Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$31.02 M
+$105.00 K+0.34%
September 30, 2024
Summary
- As of February 8, 2025, ELEV quarterly total long term liabilities is $31.02 million, with the most recent change of +$105.00 thousand (+0.34%) on September 30, 2024.
- Over the past year, ELEV quarterly long term liabilities has stayed the same.
- ELEV quarterly long term liabilities is now -68.09% below its all-time high of $97.20 million, reached on December 31, 2020.
Performance
ELEV Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
ELEV Long Term Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +2.4% | 0.0% |
3 y3 years | -69.0% | +5.4% |
5 y5 years | +319.1% | +5.4% |
ELEV Long Term Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | >+9999.0% | at high | >+9999.0% |
5 y | 5-year | -69.0% | >+9999.0% | -68.1% | >+9999.0% |
alltime | all time | -69.0% | >+9999.0% | -68.1% | >+9999.0% |
Elevation Oncology Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $31.02 M(+0.3%) |
Jun 2024 | - | $30.92 M(+0.3%) |
Mar 2024 | - | $30.81 M(+2.2%) |
Dec 2023 | $30.14 M(+2.4%) | $30.14 M(+0.6%) |
Sep 2023 | - | $29.95 M(+0.6%) |
Jun 2023 | - | $29.77 M(+0.6%) |
Mar 2023 | - | $29.60 M(+0.6%) |
Dec 2022 | $29.44 M | $29.44 M(+0.6%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2022 | - | $29.27 M(>+9900.0%) |
Jun 2022 | - | $5000.00(-28.6%) |
Mar 2022 | - | $7000.00(-12.5%) |
Dec 2021 | $8000.00(-100.0%) | $8000.00(-20.0%) |
Sep 2021 | - | $10.00 K(-16.7%) |
Jun 2021 | - | $12.00 K(-100.0%) |
Mar 2021 | - | $97.20 M(-0.0%) |
Dec 2020 | $97.20 M(+1251.9%) | $97.20 M |
Dec 2019 | $7.19 M | - |
FAQ
- What is Elevation Oncology annual total long term liabilities?
- What is the all time high annual total long term liabilities for Elevation Oncology?
- What is Elevation Oncology annual total long term liabilities year-on-year change?
- What is Elevation Oncology quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Elevation Oncology?
- What is Elevation Oncology quarterly long term liabilities year-on-year change?
What is Elevation Oncology annual total long term liabilities?
The current annual total long term liabilities of ELEV is $30.14 M
What is the all time high annual total long term liabilities for Elevation Oncology?
Elevation Oncology all-time high annual total long term liabilities is $97.20 M
What is Elevation Oncology annual total long term liabilities year-on-year change?
Over the past year, ELEV annual total long term liabilities has changed by +$700.00 K (+2.38%)
What is Elevation Oncology quarterly total long term liabilities?
The current quarterly long term liabilities of ELEV is $31.02 M
What is the all time high quarterly long term liabilities for Elevation Oncology?
Elevation Oncology all-time high quarterly total long term liabilities is $97.20 M
What is Elevation Oncology quarterly long term liabilities year-on-year change?
Over the past year, ELEV quarterly total long term liabilities has changed by $0.00 (0.00%)